LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration.

LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration.
复制标题

PCa 中 LMO3 下调:与免疫浸润相关的前瞻性生物标志物

DOI:
10.3389/fgene.2022.945151
复制
发表时间:
2022
影响因子:
3.7
通讯作者:
Jiang, Hongyang
Jiang, Hongyang
中科院分区:
生物学3区
文献类型:
--
作者:
Xu, Wenchao;Sun, Taotao;Wang, Jiaxin;Li, Hao;Chen, Bingliang;Zhou, Yingjian;Wang, Tao;Wang, Shaogang;Liu, Jihong;Jiang, Hongyang

文献摘要

参考文献

被引文献

相似文献

前列腺癌是新发癌症病例的第三大原因,也是全球男性中第二常见的肿瘤类型。LMO 3在某些癌症中起着至关重要的作用;然而,LMO 3在PCa中的预后价值仍然模糊。在这里,我们利用各种网络数据库,详细阐明LMO 3在前列腺癌的预后价值和分子功能。PCa中LMO 3表达显著降低。LMO 3低表达与性别、年龄和TNM分期相关,预测PCa患者预后不良。功能富集分析表明LMO 3参与细胞外基质和免疫应答。此外,LMO 3与免疫浸润水平和许多免疫标志物呈正相关。LMO 3可作为前列腺癌免疫浸润的生物标志物。
Prostate cancer is the third leading cause of new cancer cases and the second most common tumor type in men globally. LMO3 has been stated to play a vital role in some cancers; however, the prognostic value of LMO3 in PCa remains vague. Here, we utilized various web databases to elucidate in detail the prognostic value and molecular functions of LMO3 in PCa. LMO3 expression was significantly decreased in PCa. Low LMO3 expression was associated with gender, age, and TNM grade and predicted a poor prognosis in PCa patients. Functional enrichment analysis suggested that LMO3 is engaged in the extracellular matrix and immune response. Moreover, LMO3 was positively correlated with immune infiltration levels and numerous immune markers. LMO3 may function as a prospective biomarker of immune infiltration in PCa.
DOI: 10.1093/bib/bbab260
发表时间: 2021-07-15
影响因子: 9.5
作者:
Maeser, Danielle;Gruener, Robert F.;Huang, Rong Stephanie
通讯作者: Huang, Rong Stephanie
DOI: 10.1093/nar/gkv007
发表时间: 2015-04-20
影响因子: 14.9
作者:
Ritchie ME;Phipson B;Wu D;Hu Y;Law CW;Shi W;Smyth GK
通讯作者: Smyth GK
DOI: 10.1038/s41585-020-00400-w
发表时间: 2021-03
期刊: Nature reviews. Urology
影响因子: --
作者:
Haffner MC;Zwart W;Roudier MP;True LD;Nelson WG;Epstein JI;De Marzo AM;Nelson PS;Yegnasubramanian S
通讯作者: Yegnasubramanian S
DOI: 10.1007/s10735-021-10047-5
发表时间: 2022-02-14
影响因子: 3.2
作者:
Kang, Yue;Pei, Wenye
通讯作者: Pei, Wenye
前列腺癌中上调的 LMO1 作为雄激素受体的新型共激活剂
DOI: 10.3892/ijo.2015.3195
发表时间: 2015-12-01
影响因子: 5.2
作者:
Gu, Hui;Liu, Tong;Li, Feng
通讯作者: Li, Feng